Zenith Alpha™ Abdominal Endovascular Graft

Cook Group

Status: Completed

Conditions: Abdominal Aortic; Aorto-iliac Aneurysm

Treatments: Device: Zenith Alpha™ Abdominal Endovascular Graft

Study type: Observational

Funder types: Industry

Identifiers

NCT03061825

15-10

Details and patient eligibility

About

The purpose of this study is to evaluate the clinical performance of the Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A patient is considered eligible for inclusion in the study if the patient has an infrarenal abdominal aortic or aorto-iliac aneurysm and is intended to be treated with the Zenith Alpha™ Abdominal Endovascular Graft

Exclusion criteria

• Life expectancy less than (<) 2 years
• Inability or refusal to give informed consent by the patient or legally authorized representative
• Unwilling or unable to comply with the study follow-up